相关实验视频

Updated: Jun 23, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

用JZL195调节化学疗法诱导的外围神经病变,通过质细胞和内分泌系统进行调节

Leejeong Kim¹, Guanghai Nan¹, Hee Young Kim¹

¹Department of Physiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Department of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|October 3, 2024

概括

化疗诱导的周围神经病变 (CIPN) 疼痛被JZL195减少,该药物向内分泌系统 (ECS) 中的酶. 这项研究揭示了JZL1955.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
在瘤学瘤学.

背景情况:

化疗诱导的周围神经病变 (CIPN) 是癌症治疗的常见,令人衰弱的副作用,其机制尚不清楚.
神经炎症,质激活,内分泌系统 (ECS) 和类似收费受体4 (TLR4) 都涉及到CIPN的发病.
针对ECS和神经炎症为CIPN提供了一个潜在的治疗策略.

研究的目的:

为了研究JZL195的治疗作用,一种脂肪酸胺基酸酶 (FAAH) 和单糖醇脂酶 (MAGL) 的双重抑制剂,对西斯普拉丁诱导的CIPN.
在CIPN的背景下,探索在质细胞中的大麻素受体和TLR4之间的关系.
阐明ECS和神经炎症在CIPN中的作用,并评估JZL195的影响.

主要方法:

在雄性C57BL/6小鼠中建立了西斯普拉丁诱导的CIPN小鼠模型.
机械体和冷体分别使用弗雷和酸盐试验进行了评估.
西方斑块和免疫组织化学被用来分析蛋白质表达,质激活,神经炎症和脊髓的背部根腺体和脊髓中的受体局部化.

主要成果:

在CIPN小鼠模型中,JZL195治疗显著缓解了机械和冷.
由JZL195抑制FAAH和MAGL调节了ECS,降低了神经炎症标记物,并抑制了质细胞激活.
发现大麻素受体与脊髓天体细胞和微质细胞中的TLR4共局,这表明存在功能相互作用.

结论:

JZL195通过调节ECS和抑制质激活,证明了在CIPN中减轻疼痛和神经炎症的治疗潜力.
这些发现表明,大麻素受体与脊髓质细胞中TLR4信号传递之间存在显著的相关性,这些细胞有助于CIPN.
用JZL195针对FAAH/MAGL提供了一种有前途的策略,用于管理化疗诱导的周围神经病变.

关键词:

化疗诱导的周围神经病变内分泌大麻素系统内分泌大麻素系统格利亚·格利亚是什么?神经炎症是一种神经炎症.收费类受体4 收费类受体4

更多相关视频

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

相关概念视频

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Diabetic Neuropathy

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...